Shared medical decision‐making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young children
暂无分享,去创建一个
[1] HUMANITARIAN ACTORS,et al. Do no harm , 2013, Nature Biotechnology.
[2] Douglas C. Miller,et al. Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma , 2011, Cancer.
[3] Annette Rid,et al. Systematic Review: The Effect on Surrogates of Making Treatment Decisions for Others , 2011, Annals of Internal Medicine.
[4] F. Barg,et al. Contrasting Parents' and Pediatricians' Perspectives on Shared Decision-Making in ADHD , 2011, Pediatrics.
[5] Glyn Elwyn,et al. Implementing shared decision making in the NHS Creation of a platform of tools to provide information to doctors and patients should be the first step in giving patients choice about their treatment , say , 2010 .
[6] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[7] E. Bouffet. Medulloblastoma in infants: the critical issues of the dilemma. , 2010, Current oncology.
[8] C. Hawkins,et al. Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma , 2009, Current oncology.
[9] J. McAdam,et al. Symptoms experienced by family members of patients in intensive care units. , 2009, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[10] L. Lafay-Cousin,et al. Current treatment approaches for infants with malignant central nervous system tumors. , 2009, The oncologist.
[11] R. Packer,et al. Management of and prognosis with medulloblastoma: therapy at a crossroads. , 2008, Archives of neurology.
[12] T. Merchant,et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] W. Reddick,et al. Understanding the cognitive impact on children who are treated for medulloblastoma. , 2007, Journal of pediatric psychology.
[14] Douglas C. Miller,et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. Mulhern,et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] D. Frappaz,et al. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. , 2005, The Lancet. Oncology.
[17] Elizabeth H Bradley,et al. Understanding the treatment preferences of seriously ill patients. , 2002, The New England journal of medicine.
[18] X Xiong,et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] L. Ross. Children, Families, and Health Care Decision Making , 1999 .
[20] H. Böttcher,et al. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation. , 1998, International journal of radiation oncology, biology, physics.
[21] J L Kepner,et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] L. Degner,et al. Preferences for Participation in Treatment Decision Making and Information Needs of Parents of Children With Cancer: A Pilot Study , 1998, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.
[23] S. Wellek,et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. , 1995, Medical and pediatric oncology.
[24] M E Cohen,et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. , 1993, The New England journal of medicine.
[25] J. Hirsch,et al. Medulloblastoma in childhood: progressive intellectual deterioration , 1990, Child's Nervous System.
[26] L. Forrow,et al. Deciding for others: The ethics of surrogate decision‐making , 1990 .
[27] A R Jonsen,et al. Do no harm. , 1978, Annals of internal medicine.
[28] R. Jenkin. Medulloblastoma in childhood: radiation therapy. , 1969, Canadian Medical Association journal.
[29] R. Hickman,et al. Impact of chronic critical illness on the psychological outcomes of family members. , 2010, AACN advanced critical care.
[30] C. Stiller. Childhood cancer in Britain : incidence, survival, mortality , 2007 .
[31] R. Arceci. Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone , 2006 .
[32] D. Diekema. Parental refusals of medical treatment: the harm principle as threshold for state intervention , 2004, Theoretical medicine and bioethics.
[33] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[34] A. Buchanan,et al. Medical paternalism. , 1978, Philosophy & public affairs.
[35] Rascon. [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.